Skip to Content
Skip to Main Navigation
Skip to Local Navigation
Skip to Search
Contact TGA:
info@tga.gov.au
|
1800 020 653
|
More contact info
Translate
|
Subscribe
Therapeutic Goods Administration (TGA)
Australian Government Department of Health
Main menu
Home
Safety information
Report a problem or side effect
Reporting adverse events involving medicines, vaccines or medical devices
Report an issue with packaging or storage of a medicine
AEMS guidance for health professionals
AEMS guidance for sponsors
Help us promote adverse event reporting: promotional resources kit
Alerts
Current year alerts
All alerts
Recalls
About Australian recall actions
Recall actions database
Uniform recall procedure
Early warning system
Monitoring communications
About the Early Warning System
Early Warning System: consumer questions and answers
Early Warning System: health professional questions and answers
Prescription opioids hub
Black Triangle Scheme
Black Triangle Scheme: Information for sponsors
Medicine shortages
Safety information & education
Medicines safety
Medical devices safety
Database of Adverse Event Notifications (DAEN)
Consumers
Report a problem or side effect
Reporting adverse events involving medicines, vaccines or medical devices
Travelling with medicines and medical devices
Leaving Australia
Entering Australia
Helpful links for travellers
Buying medicines and medical devices online
Counterfeit medicines and devices
Can I import it?
Personal importation scheme
Medicinal cannabis: importation and the traveller's exemption
Medicines
How we regulate medicines
Prescription medicines
Complementary medicines
Over-the-counter (OTC) medicines
Vaccines
What's on my medicine label?
Medical devices
Medical devices overview
Transvaginal (urogynaecological) surgical mesh hub
Breast implant hub
Cosmetic injections
Medical device cyber security
Advertising hub
Consumer information & education
Safety information for consumers
Medicines & medical devices
Community Q&A
MedSearch | Medicine information search app
Other web resources for consumers
Medicinal cannabis products
Health professionals
Report a problem or side effect
Reporting adverse events involving medicines, vaccines or medical devices
Accessing unapproved products
Special access scheme
Authorised prescribers
Clinical trials
Personal import scheme
Accessing medicines during a medicine shortage
Access to medicinal cannabis products
Advertising
Medicines
Medical devices
Biologicals
Safety information
Other resources
Industry
SME Assist
Basics of therapeutic goods regulation
Overview of applying for market authorisation
Medical devices regulation: an introduction
When to engage with the TGA
Useful resources for business
Is my product a therapeutic good?
What classification is my medical device?
Which clinical trial scheme should I choose?
What type of GMP application do I require?
Training sessions
What do I require to have a listed medicine in the ARTG?
Regulation basics
How therapeutic goods are regulated in Australia
Australian Register of Therapeutic Goods
Industry educational materials
Legislation & legislative instruments
Advertising hub
Labelling & packaging
Ingredients in therapeutic goods
Exporting therapeutic goods
Importing therapeutic goods
Clinical trials
Cosmetics
Scientific guidelines
Safety information for industry
Prescription medicines
Australian Regulatory Guidelines for Prescription Medicines
Prescription medicines regulation basics
Standards and guidelines
Forms for prescription medicine sponsors
Regulatory decisions and notices
Over-the-counter medicines
OTC medicines regulation basics
Standards, guidelines and publications
Forms for OTC medicine sponsors
Regulatory decisions and notices
Complementary medicines
Complementary medicine regulation basics
Standards, guidelines and publications
Forms for complementary medicine sponsors
Complementary medicines reforms
Regulatory decisions and notices
Sunscreens
Sunscreens regulation basics
Standards, guidelines and publications
Sunscreen reforms
Medical devices & IVDs
Medical devices regulation basics
IVD medical devices regulation basics
Standards, guidelines and publications
Forms for medical device & IVD sponsors
Medical devices reforms
Regulatory decisions and notices
Biologicals
Australian Regulatory Guidelines for Biologicals
Regulatory framework for biologicals
Biological standards
Forms for the biologicals industry
Regulatory decisions and notices
Blood and blood components
Regulation of blood
Regulation of platelet-rich plasma (PRP), platelet-rich fibrin (PRF) and conditioned serum
Forms for the blood and blood components industry
Other therapeutic goods
Disinfectants, sterilants and sanitary products
Tampons & menstrual cups
Manufacturing therapeutic goods
Manufacturing basics
Manufacturing medicines
Manufacturing medical devices & IVDs
Manufacturing biologicals
Manufacturing blood and blood components
Manufacturing inspections
Forms for manufacturers
Notices for manufacturers
Notices about GMP clearance
Scheduling of medicines & poisons
Scheduling basics
Scheduling committees meeting dates and decisions timeframes
The Poisons Standard (the SUSMP)
Public notices about scheduling
State/Territory scheduling information
About the TGA
TGA basics
Who we are & what we do
What the TGA doesn't do
Structure
TGA plans & reports
TGA reforms
Publications
Forms
Freedom of information
Acronyms & glossary
TGA Internet site
Social media
Contact the TGA
How can we help?
TGA customer service standards
Report a perceived breach or questionable practices
Website feedback or error reporting
Translate this website
Educational materials
For consumers
For health professionals
For industry
For university students
Education priorities 2018-19
Advertising hub
Advertising basics, general information and enquiries
Advertising Code and guidance
Complaints and outcomes
Sanctions and penalties
Education, training and events
Regulatory decisions and announcements
Stakeholder engagement and reforms
Compliance and enforcement hub
Compliance management
Compliance actions and outcomes
News and information
Report a breach
Regulatory decisions & notices
Consent to import, supply or export goods that do not comply with standards
Cancellation requested by the sponsor - regulatory actions
Failure to pay annual charges - regulatory actions
TGA laboratory testing results
Decisions to withdraw medicines advertising approval
S19A approval notices
Committees
TGA statutory advisory committees
Other committees
Employment & job vacancies
Working for the TGA
Recruitment information
Living in Canberra
Fees and payments
Schedule of fees and charges
Payment options
Information & notices about TGA fees & payments
Cost recovery implementation statements
Forms (fees and payments)
Annual Charge Exemption (ACE) scheme
TGA Business Services
TGA Business services: getting started with the TGA
TGA Business services - how to use the site
TGA Business Services forms
International
International activities
International cooperation
Use of international assessments
TGA international engagement strategy
Links to international agencies & organisations
TGA Internet site archive
Archived committee information
Archived consultations & reviews
Archived media releases
Archived presentations
Archived regulatory decisions & notices
Archived TGA publications & articles
Archived Behind the news
News room
News & public notices
Latest news & updates
Media releases & statements
Behind the news
Newsletters & articles
Subscribe to updates
TGA tenders
TGA laboratory testing reports
Consultations & reviews
Open consultations & reviews
Closed consultations & reviews
About consultations
Consultation forecast
Medicines and Medical Devices Regulation Review hub
Events, training & presentations
Events & training
Presentations
Blog
TGA topics
Decrease the text size
Increase the text size
Print this page
Share
You are here
Home
»
Safety information
»
Alerts
Current year alerts
Related information
All alerts
About alerts
Medicines Safety Update
Medical Devices Safety Update
Subscribe to updates
November
October
September
August
July
May
April
March
February
January
November
Current status of breast implant products in Australia
18 November 2019
The list of current ARTG entries for breast implants has been updated
Accu-Chek Guide and Accu-Chek Performa blood glucose meters
14 November 2019
Product defect correction – risk of delayed therapy due to potential battery issues
De2Xy capsules
14 November 2019
De2Xy capsules pose a serious risk to your health and should not be taken
Me2Shape capsules
13 November 2019
Me2Shape capsules pose a serious risk to your health and should not be taken.
Grakcu capsules
6 November 2019
Grakcu capsules pose a serious risk to your health and should not be taken
Prescription opioids hub
5 November 2019
New resources for health professionals added
October
Gentamicin Injection USP 40 mg/mL (80 mg/2 mL) ampoules
25 October 2019
Safety advisory - alternative product filling shortage may cause airway irritation if administered via inhalation
Ranitidine
22 October 2019
Update - contamination with N-nitrosodimethylamine
Tofacitinib
15 October 2019
Update - Warning about increased risks of blood clots and of death at higher dose for certain patients
Febuxostat (Adenuric) tablets
1 October 2019
Safety advisory – increased risk of death in gout patients with a history of major cardiovascular disease
September
Slimina Weight Loss capsules
20 September 2019
Slimina Weight Loss capsules pose a serious risk to your health and should not be taken
Arthrem capsules
19 September 2019
Update to safety advisory
Ballerina Anti-Obesity capsules
18 September 2019
Ballerina Anti-Obesity capsules pose a serious risk to your health and should not be taken
Ranitidine
17 September 2019
Potential contamination of ranitidine with the N-nitroso compound NDMA
Jin Gui Shen Qi Wan (oral pills)
5 September 2019
Recall - potential toxicity (金 匮 肾 气 丸 - statement includes Chinese translation 中文翻译)
August
Bali Mojo capsules
9 August 2019
Bali Mojo capsules pose a serious risk to your health and should not be taken
Hong Kong Tianli Biological – power tablet
9 August 2019
Hong Kong Tianli Biological - Power tablets pose a serious risk to your health and should not be taken
Allergan macro-textured breast implants and tissue expanders
2 August 2019
Hazard alert – risk of breast implant-associated anaplastic large cell lymphoma in rare cases
July
Endone 5 mg tablets
30 July 2019
Product defect correction – potential for incorrect medicine in the pack
Neutrogena Visibly Clear Light Therapy Acne Mask and Activator
17 July 2019
Recall - Potential for eye damage
Slim Perfect Legs + High Fiber capsules
2 July 2019
Slim Perfect Legs + High Fiber capsules pose a serious risk to your health and should not be taken
GoLean Detox capsules
1 July 2019
GoLean Detox capsules pose a serious risk to your health and should not be taken
May
Curam Duo 400/57
22 May 2019
Recall – potential for reduced effectiveness
Hair Tonic and Hairpro capsules
21 May 2019
Recall - risk of liver injury
TGA actions after review into urogynaecological surgical mesh implants
17 May 2019
Update to Mesh Hub notifying of recent recall actions
Glyceryl trinitrate tablets (Anginine and Lycinate)
2 May 2019
Update 4 - continuing medicine shortage
Metronidazole intravenous infusion 500 mg/100 mL bag
2 May 2019
Update - medicine shortage resolved
Vitex agnus-castus
2 May 2019
Safety advisory – potential for interaction with oral contraceptives
April
Weleda Baby Teething Powder 60 g
29 April 2019
Recall - ingestion of plastic fragments may pose potential choking hazard
Double Maxx D.B.M. Capsules
18 April 2019
Double Maxx D.B.M. Capsules pose a serious risk to your health and should not be taken.
BMSW 4600MG Black Ant Capsules
17 April 2019
BMSW 4600MG Black Ant Capsules pose a serious risk to your health and should not be taken
Japan Tengsu tablets
17 April 2019
Japan Tengsu tablets pose a serious risk to your health and should not be taken
Horny Little Devil Capsules
17 April 2019
Horny Little Devil Capsules pose a serious risk to your health and should not be taken
2019 seasonal influenza vaccines
17 April 2019
Information for consumers and health professionals
Infections associated with heater-cooler devices
16 April 2019
Statement on the post-market review of heater-coolers has been updated
Lotus Flower capsules
3 April 2019
Lotus Flower capsules pose a serious risk to your health and should not be taken
Magnum XXL capsules
3 April 2019
Magnum XXL capsules pose a serious risk to your health and should not be taken
X Power 3 tablets
3 April 2019
X Power 3 tablets pose a serious risk to your health and should not be taken
JOYSMI capsules
3 April 2019
JOYSMI capsules pose a serious risk to your health and should not be taken
Meizitang Botanical soft gel capsules
3 April 2019
Meizitang Botanical soft gel capsules pose a serious risk to your health and should not be taken.
Mylanta Antacid Double Strength Oral Liquid 500 mL
1 April 2019
Product defect correction - potential for soft lumps in the liquid
March
Make Coarser Make Bigger capsules
18 March 2019
Make Coarser Make Bigger capsules pose a serious risk to your health and should not be taken.
Morphine Sulfate Injection BP 30 mg in 1 mL ampoule
5 March 2019
Safety advisory – Section 19A product not for epidural or intrathecal use
February
'Sartan' blood pressure medicines
26 February 2019
TGA investigation - potential contamination with N -nitroso compounds
ISHOU Fulin Ruan Jiaonang capsules
25 February 2019
ISHOU Fulin Ruan Jiaonang capsules pose a serious risk to your health and should not be taken
BASCHI Quick Slimming capsules
25 February 2019
BASCHI Quick Slimming capsules pose a serious risk to your health and should not be taken
Deli by New Queen capsules
22 February 2019
Deli by New Queen capsules pose a serious risk to your health and should not be taken
Boxy Indelar capsules
18 February 2019
Boxy Indelar capsules pose a serious risk to your health and should not be taken
Mang Luk Power Slim capsules
18 February 2019
Mang Luk Power Slim capsules pose a serious risk to your health and should not be taken
Jurnista (hydromorphone hydrochloride) prolonged-release
13 February 2019
Product defect correction - potentially damaged tablets
January
ConvaTec Australia devices
25 January 2019
Recall of multiple products - potential for breaches of sterile packaging
EpiPen 300 mcg adrenaline auto-injector
23 January 2019
Update - medicine shortage resolved
OA/RA capsules
23 January 2019
Recall due to contamination
St John Ambulance Tiny Tots First Aid Kit - electronic thermometer
21 January 2019
Recall - potential risk of harm for children who access the button battery
Germany Black Ant 2000mg tablets (Zhansheng Weige Chaoyue Xilishi)
15 January 2019
These tablets pose a serious risk to your health and should not be taken
The Therapeutic Goods Administration is part of the Health Products Regulation Group
